B-type natriuretic peptide in patients with clinical hyperthyroidism

Tiemin Wei, Chunlai Zeng, Y Tian, Qunying Chen, Lexin Wang

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)


Aims: To investigate the level and clinical significance of plasma B-type natriuretic peptide (BNP) in patients with hyperthyroidism. Methods: Plasma BNP was measured in 32 healthy subjects and 67 patients with clinical hyperthyroidism. Left ventricular anatomy and function was assessed with echocardiography. Results: The average BNP in hyperthyroid patients was higher than that in healthy subjects (186'140 vs 34'17 ng/l, p=0.001). The increase in BNP was mainly found in hyperthyroid patients who had clinical and echocardiographic evidence of left ventricular dysfunction (250'190 ng/l). The BNP level in patients with hyperthyroidism, but with normal left ventricular function, was similar to that of the controls (37'17 vs 34'17, ng/l, p>0.05). Multi-regression analysis showed that left atrial diameter and left ventricular ejection fraction were independently associated with the plasma levels of BNP. Conclusions: there is a significant elevation in plasma BNP in patients with hyperthyroidism; the increase is largely due to hyperthyroidism-induced left ventricular dysfunction. Measurements of plasma BNP may help to detect heart failure in patients with clinical hyperthyroidism.
Original languageEnglish
Pages (from-to)8-11
Number of pages4
JournalJournal of Endocrinological Investigation
Issue number1
Publication statusPublished - 2005


Dive into the research topics of 'B-type natriuretic peptide in patients with clinical hyperthyroidism'. Together they form a unique fingerprint.

Cite this